Imperial College London and King's College London hope to profit from partnerships with venture capitalists. Imperial plans to raise £50 million to invest in spin-off companies from its partnership with specialist biosciences fund manager, BioScience Managers Ltd. King's has signed a £5 million agreement with IP2IPO, a subsidiary of an investment bank. IP2IPO will invest in the college's spin-off companies over the next five years, in return for a 20 per cent share of the college's interest in them.
Register to continue
Why register?
- Registration is free and only takes a moment
- Once registered, you can read 3 articles a month
- Sign up for our newsletter
Subscribe
Or subscribe for unlimited access to:
- Unlimited access to news, views, insights & reviews
- Digital editions
- Digital access to THE’s university and college rankings analysis
Already registered or a current subscriber?
Please or to read this article.
